Search results
Results from the WOW.Com Content Network
Metronomic therapy is a new type of chemotherapy in which anti-cancer drugs are administered in a lower dose than the maximum tolerated dose repetitively over a long period to treat cancers with fewer side effects. Metronomic therapy is shown to affect both tumor microenvironment and tumor cells to achieve its therapeutic effects. [1]
Metronomic chemotherapy, which involves regularly giving patients low dosages of chemotherapy drugs, is one instance of this. [46] This technique has been shown to have the potential to change the tumor microenvironment and limit tumor growth. [47] It is yet unknown how best to employ metronomic chemotherapy, especially for varied cancer types ...
Metronomic therapy; V. VAMP regimen This page was last edited on 3 March 2013, at 19:15 (UTC). Text is available under the Creative Commons Attribution ...
Combined modality chemotherapy is the use of drugs with other cancer treatments, such as surgery, radiation therapy, or hyperthermia therapy. Consolidation chemotherapy is given after remission in order to prolong the overall disease-free time and improve overall survival. The drug that is administered is the same as the drug that achieved ...
Tegafur/uracil (abbreviation: UFT [1]) is a chemotherapy drug combination used in the treatment of cancer, primarily bowel cancer.. UFT is an oral formulation combining uracil (a competitive inhibitor of dihydropyrimidine dehydrogenase), and tegafur (a bioavailable 5-fluorouracil (5-FU) prodrug) in a 4:1 molar ratio.
Performances that are unfailingly regular rhythmically might be criticized as being metronomic, lacking the characteristic swing of the genre. [52] Some have argued that "the metronome has no real musical value", hurting rather than helping musicians' sense of rhythm.
C cell – c-erbB-2 – c-kit – CA 19-9 assay – CA-125 – CA-125 test – cachexia – calcitonin – calcitriol – CAM – Campath-1H – camptothecin – camptothecin analog – cancer – cancer induction – Cancer Information Service – cancer of unknown primary origin – cancer stem cell – cancer vaccine – Cancer.gov – Candidiasis – Candidosis – CAP-1 – capecitabine ...
JX-594 is an oncolytic virus is designed to target and destroy cancer cells. [1] It is also known as Pexa-Vec, [2] INN pexastimogene devacirepvec [3]) and was constructed in Dr. Edmund Lattime's lab at Thomas Jefferson University, tested in clinical trials on melanoma patients, and licensed and further developed by SillaJen.